Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $19.65 $24.19 Monday, 13th May 2024 PRTA stock ended at $20.71. This is 2.95% less than the trading day before Friday, 10th May 2024. During the day the stock fluctuated 5.72% from a day low at $20.65 to a day high of $21.83.
90 days $19.65 $31.01
52 weeks $19.65 $77.11

Historical Prothena Corporation plc prices

Date Open High Low Close Volume
Feb 16, 2016 $32.10 $33.14 $30.50 $31.96 423 400
Feb 12, 2016 $31.02 $31.95 $29.49 $31.51 596 200
Feb 11, 2016 $31.21 $31.71 $29.34 $30.12 579 000
Feb 10, 2016 $31.23 $34.36 $29.86 $31.97 775 700
Feb 09, 2016 $30.15 $32.60 $28.20 $30.94 517 900
Feb 08, 2016 $33.89 $34.92 $31.54 $31.71 1 063 300
Feb 05, 2016 $36.71 $38.20 $33.70 $34.27 1 378 200
Feb 04, 2016 $36.58 $39.07 $35.64 $36.77 532 900
Feb 03, 2016 $37.52 $38.16 $35.01 $36.75 878 200
Feb 02, 2016 $38.64 $38.70 $35.28 $37.14 636 200
Feb 01, 2016 $38.76 $39.96 $37.25 $39.45 666 900
Jan 29, 2016 $36.82 $39.35 $36.45 $38.95 1 110 500
Jan 28, 2016 $38.17 $38.79 $35.48 $37.07 596 100
Jan 27, 2016 $38.38 $40.00 $37.09 $37.66 1 162 800
Jan 26, 2016 $41.33 $41.50 $37.50 $38.51 980 800
Jan 25, 2016 $40.91 $43.08 $40.25 $40.97 525 600
Jan 22, 2016 $41.19 $42.15 $39.74 $41.57 604 000
Jan 21, 2016 $43.96 $43.96 $40.00 $40.10 579 500
Jan 20, 2016 $42.42 $44.63 $39.37 $43.09 682 500
Jan 19, 2016 $46.53 $46.89 $41.62 $43.35 961 300
Jan 15, 2016 $45.01 $46.35 $43.39 $45.82 818 000
Jan 14, 2016 $46.12 $47.55 $42.26 $46.51 913 600
Jan 13, 2016 $51.78 $52.33 $45.97 $46.12 593 600
Jan 12, 2016 $49.28 $53.98 $48.58 $51.56 979 200
Jan 11, 2016 $54.35 $54.97 $47.62 $48.43 671 600
Click to get the best stock tips daily for free!

About Prothena Corporation plc

Prothena  plc Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease... PRTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT